|Articles|January 19, 2023
Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies
Author(s)Curia
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
2
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
3
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
4
Industry Experts Probe CNPV Impacts: Part II
5
